Global Hematology Oncology Market By Hematology Products (Hematology Analyzers, Hematology Reagents, Flow Cytometers, Hematology Cell Counters, Slide Strainers, Coagulation Analyzers, Others), By Applications (Infectious Diseases, Cancer, Cardiovascular Disorders, Blood Screening, Diabetes, HIV, Auto-Immune Diseases), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-Testings), By Oncology Drug Class Types, By Oncology Indications, By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Published date: Jan 2022
Report ID: 73804
Number of Pages: 292
Format:

- 1.Hematology Oncology Market Introduction
  - 1.1.Definition
  - 1.2.Taxonomy
  - 1.3.Research Scope
- 2.Executive Summary
  - 2.1.Key Findings by Major Segments
  - 2.2.Top strategies by Major Players
- 3.Global Hematology Oncology Market Overview
  - 3.1.Hematology Oncology Market Dynamics
    3.1.1.Drivers
    3.1.2.Opportunities
    3.1.3.Restraints
    3.1.4.Challenges
  - 3.2.COVID-19 Impact Analysis
  - 3.3.COVID-19 Impact Analysis in Global Hematology Oncology Market
  - 3.4.PESTLE Analysis
  - 3.5.Opportunity Map Analysis
  - 3.6.PORTER'S Five Forces Analysis
  - 3.7.Market Competition Scenario Analysis
  - 3.8.Product Life Cycle Analysis
  - 3.9.Opportunity Orbits
  - 3.10.Manufacturer Intensity Map
  - 3.11.Major Companies sales by Value & Volume
- 4.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Hematology Products, 2015-2031
  - 4.1.Global Hematology Oncology Market Analysis by Hematology Products: Introduction
  - 4.2.Market Size and Forecast by Region
  - 4.3.Hematology Analyzers
  - 4.4.Hematology Reagents
  - 4.5.Flow Cytometers
  - 4.6.Hematology Cell Counters
  - 4.7.Slide Strainers
  - 4.8.Coagulation Analyzers
  - 4.9.Hematology Testing
  - 4.10.Centrifuges
  - 4.11.Hemoglobin Meters
  - 4.12.Other Hematology Products
- 5.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Oncology Drug Class Types, 2015-2031
  - 5.1.Global Hematology Oncology Market Analysis by Oncology Drug Class Types: Introduction
  - 5.2.Market Size and Forecast by Region
  - 5.3.Chemotherapy
  - 5.4.Targeted Therapy
  - 5.5.Immunotherapy
  - 5.6.Hormonal Therapy
- 6.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Oncology Indications, 2015-2031
  - 6.1.Global Hematology Oncology Market Analysis by Oncology Indications: Introduction
  - 6.2.Market Size and Forecast by Region
  - 6.3.Lung Cancer
  - 6.4.Stomach Cancer
  - 6.5.Colorectal Cancer
  - 6.6.Breast Cancer
  - 6.7.Prostate Cancer
  - 6.8.Liver Cancer
  - 6.9.Esophagus Cancer
  - 6.10.Cervical Cancer
  - 6.11.Kidney Cancer
  - 6.12.Bladder Cancer
  - 6.13.Other Oncology Indications
- 7.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Applications, 2015-2031
  - 7.1.Global Hematology Oncology Market Analysis by Applications: Introduction
  - 7.2.Market Size and Forecast by Region
  - 7.3.Infectious Diseases
  - 7.4.Cancer
  - 7.5.Cardiovascular Disorders
  - 7.6.Blood Screening
  - 7.7.Diabetes
  - 7.8.HIV
  - 7.9.Auto-Immune Diseases
- 8.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-Users, 2015-2031
  - 8.1.Global Hematology Oncology Market Analysis by End-Users: Introduction
  - 8.2.Market Size and Forecast by Region
  - 8.3.Hospitals
  - 8.4.Clinical Testing Institutes
  - 8.5.Patient Self-Testings
  - 8.6.Other End-Users
- 9.Global Hematology Oncology Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2015-2031
  - 9.1.North America
    9.1.1.North America Hematology Oncology Market: Regional Trend Analysis
    9.1.1.1.U.S.
    9.1.1.2.Canada
    9.1.1.3.Mexico
  - 9.2.1.Europe
    9.2.1.Europe Hematology Oncology Market: Regional Trend Analysis
    9.2.1.1.U.K.
    9.2.1.2.Germany
    9.2.1.3.France
    9.2.1.4.Spain
    9.2.1.5.Italy
    9.2.1.6.Russia
    9.2.1.7.Rest of Europe
  - 9.3.Asia-Pacific
    9.3.1.Asia-Pacific Hematology Oncology Market: Regional Trend Analysis
    9.3.1.1.China
    9.3.1.2.Japan
    9.3.1.3.South Korea
    9.3.1.4.India
    9.3.1.5.ASEAN
    9.3.1.6.Rest of Asia-Pacific
  - 9.4.Latin America
    9.4.1.Latin America Hematology Oncology Market: Regional Trend Analysis
    9.4.1.1.Brazil
    9.4.1.2.Argentina
    9.4.1.3.Rest of Latin America
  - 9.5.Middle East and Africa
    9.5.1.Middle East and Africa Hematology Oncology Market: Regional Trend Analysis
    9.5.1.1.GCC
    9.5.1.2.Israel
    9.5.1.3.South Africa
    9.5.1.4.Rest of MEA
- 10.Global Hematology Oncology Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 10.1.Market Share Analysis
  - 10.2.Company Profiles
  - 10.3.Abbott Laboratories
    10.3.1.Company Overview
    10.3.2.Financial Highlights
    10.3.3.Product Portfolio
    10.3.4.SWOT Analysis
    10.3.5.Key Strategies and Developments
  - 10.4.Bio-Rad Laboratories Inc.
    10.4.1.Company Overview
    10.4.2.Financial Highlights
    10.4.3.Product Portfolio
    10.4.4.SWOT Analysis
    10.4.5.Key Strategies and Developments
  - 10.5.Danaher Corporation
    10.5.1.Company Overview
    10.5.2.Financial Highlights
    10.5.3.Product Portfolio
    10.5.4.SWOT Analysis
    10.5.5.Key Strategies and Developments
  - 10.6.F. Hoffmann-La Roche Ltd.
    10.6.1.Company Overview
    10.6.2.Financial Highlights
    10.6.3.Product Portfolio
    10.6.4.SWOT Analysis
    10.6.5.Key Strategies and Developments
  - 10.7.Novo Nordisk A/S
    10.7.1.Company Overview
    10.7.2.Financial Highlights
    10.7.3.Product Portfolio
    10.7.4.SWOT Analysis
    10.7.5.Key Strategies and Developments
  - 10.8.PerkinElmer Inc.
    10.8.1.Company Overview
    10.8.2.Financial Highlights
    10.8.3.Product Portfolio
    10.8.4.SWOT Analysis
    10.8.5.Key Strategies and Developments
  - 10.9.Thermo Fisher Scientific Inc.
    10.9.1.Company Overview
    10.9.2.Financial Highlights
    10.9.3.Product Portfolio
    10.9.4.SWOT Analysis
    10.9.5.Key Strategies and Developments
  - 10.10.AbbVie Inc.
    10.10.1.Company Overview
    10.10.2.Financial Highlights
    10.10.3.Product Portfolio
    10.10.4.SWOT Analysis
    10.10.5.Key Strategies and Developments
  - 10.11.Astellas Pharma Inc.
    10.11.1.Company Overview
    10.11.2.Financial Highlights
    10.11.3.Product Portfolio
    10.11.4.SWOT Analysis
    10.11.5.Key Strategies and Developments
  - 10.12.AstraZeneca
    10.12.1.Company Overview
    10.12.2.Financial Highlights
    10.12.3.Product Portfolio
    10.12.4.SWOT Analysis
    10.12.5.Key Strategies and Developments
  - 10.13.Bristol-Myers Squibb Company
    10.13.1.Company Overview
    10.13.2.Financial Highlights
    10.13.3.Product Portfolio
    10.13.4.SWOT Analysis
    10.13.5.Key Strategies and Developments
  - 10.14.Celgene Corporation
    10.14.1.Company Overview
    10.14.2.Financial Highlights
    10.14.3.Product Portfolio
    10.14.4.SWOT Analysis
    10.14.5.Key Strategies and Developments
  - 10.15.Johnson & Johnson Services Inc.
    10.15.1.Company Overview
    10.15.2.Financial Highlights
    10.15.3.Product Portfolio
    10.15.4.SWOT Analysis
    10.15.5.Key Strategies and Developments
  - 10.16.Merck & Co. Inc.
    10.16.1.Company Overview
    10.16.2.Financial Highlights
    10.16.3.Product Portfolio
    10.16.4.SWOT Analysis
    10.16.5.Key Strategies and Developments
  - 10.17.Beckman Coulter Inc.
    10.17.1.Company Overview
    10.17.2.Financial Highlights
    10.17.3.Product Portfolio
    10.17.4.SWOT Analysis
    10.17.5.Key Strategies and Developments
- 11.Assumptions and Acronyms
- 12.Research Methodology
- 13.Contact
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Danaher Corporation Company Profile
- F. Hoffmann-La Roche Ltd.
- Novo Nordisk A/S Company Profile
- PerkinElmer Inc.
- Thermo Fisher Scientific Company Profile
- AbbVie Inc. Company Profile
- Astellas Pharma Inc.
- AstraZeneca Plc Company Profile
- Bristol-Myers Squibb Company
- Celgene Corporation
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Beckman Coulter Inc.
- others
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)